James Schultz

Array ( [id] => 6730713 [patent_doc_number] => 20030186903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Antisense modulation of MyD88 expression' [patent_app_type] => new [patent_app_number] => 10/021707 [patent_app_country] => US [patent_app_date] => 2001-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25751 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186903.pdf [firstpage_image] =>[orig_patent_app_number] => 10021707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923085 [patent_doc_number] => 20020115628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => '47169 and 33935, novel human glycosyl transferases and uses thereof' [patent_app_type] => new [patent_app_number] => 10/001851 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 39561 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115628.pdf [firstpage_image] =>[orig_patent_app_number] => 10001851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651292 [patent_doc_number] => 20030105041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Antisense modulation of SHH expression' [patent_app_type] => new [patent_app_number] => 10/001844 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25155 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105041.pdf [firstpage_image] =>[orig_patent_app_number] => 10001844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5908564 [patent_doc_number] => 20020143166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Method for removing a universal linker from an oligonucleotide' [patent_app_type] => new [patent_app_number] => 09/986750 [patent_app_country] => US [patent_app_date] => 2001-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3428 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20020143166.pdf [firstpage_image] =>[orig_patent_app_number] => 09986750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651296 [patent_doc_number] => 20030105042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Antisense modulation of EIF2C1 expression' [patent_app_type] => new [patent_app_number] => 10/007078 [patent_app_country] => US [patent_app_date] => 2001-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25896 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105042.pdf [firstpage_image] =>[orig_patent_app_number] => 10007078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761912 [patent_doc_number] => 20030125274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Antisense modulation of human collapsin response mediator protein 2 expression' [patent_app_type] => new [patent_app_number] => 10/006911 [patent_app_country] => US [patent_app_date] => 2001-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25265 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125274.pdf [firstpage_image] =>[orig_patent_app_number] => 10006911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745875 [patent_doc_number] => 20030023058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Antisense human fucosyltransferase sequences and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/005715 [patent_app_country] => US [patent_app_date] => 2001-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10770 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20030023058.pdf [firstpage_image] =>[orig_patent_app_number] => 10005715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792466 [patent_doc_number] => 20030087810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Peptides that deliver antisense oligonucleotides which downregulate protein expression in cells' [patent_app_type] => new [patent_app_number] => 10/002884 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6485 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087810.pdf [firstpage_image] =>[orig_patent_app_number] => 10002884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766124 [patent_doc_number] => 20030100524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Antisense modulation of phospholipase A2 group V expression' [patent_app_type] => new [patent_app_number] => 10/016149 [patent_app_country] => US [patent_app_date] => 2001-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25191 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100524.pdf [firstpage_image] =>[orig_patent_app_number] => 10016149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651297 [patent_doc_number] => 20030105043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Apoptosis-inducing ribozymes' [patent_app_type] => new [patent_app_number] => 10/033024 [patent_app_country] => US [patent_app_date] => 2001-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13677 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105043.pdf [firstpage_image] =>[orig_patent_app_number] => 10033024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046877 [patent_doc_number] => 20020168365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Method for modulating granzyme B uptake and for identifying modulators thereof' [patent_app_type] => new [patent_app_number] => 10/000789 [patent_app_country] => US [patent_app_date] => 2001-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26191 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20020168365.pdf [firstpage_image] =>[orig_patent_app_number] => 10000789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6546334 [patent_doc_number] => 20020110892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Human RNase H and compositions and uses thereof' [patent_app_type] => new [patent_app_number] => 10/054313 [patent_app_country] => US [patent_app_date] => 2001-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6042 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20020110892.pdf [firstpage_image] =>[orig_patent_app_number] => 10054313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651277 [patent_doc_number] => 20030105038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Antisense modulation of CREB expression' [patent_app_type] => new [patent_app_number] => 09/973827 [patent_app_country] => US [patent_app_date] => 2001-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25755 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105038.pdf [firstpage_image] =>[orig_patent_app_number] => 09973827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 675933 [patent_doc_number] => 07087584 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-08 [patent_title] => 'Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease' [patent_app_type] => utility [patent_app_number] => 09/974592 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 31 [patent_no_of_words] => 19003 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/087/07087584.pdf [firstpage_image] =>[orig_patent_app_number] => 09974592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016054 [patent_doc_number] => 20020102711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Novel human cystatin-like protein' [patent_app_type] => new [patent_app_number] => 09/969834 [patent_app_country] => US [patent_app_date] => 2001-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17453 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102711.pdf [firstpage_image] =>[orig_patent_app_number] => 09969834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5905728 [patent_doc_number] => 20020142325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'PAK 2: modulators of lymphocyte activation' [patent_app_type] => new [patent_app_number] => 09/967624 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 22555 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142325.pdf [firstpage_image] =>[orig_patent_app_number] => 09967624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6176134 [patent_doc_number] => 20020155535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Novel human cysteine protease' [patent_app_type] => new [patent_app_number] => 09/967796 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12856 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155535.pdf [firstpage_image] =>[orig_patent_app_number] => 09967796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6567965 [patent_doc_number] => 20020165181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Carbohydrate or 2\' -modified oligonucleotides having alternating internucleoside linkages' [patent_app_type] => new [patent_app_number] => 09/965551 [patent_app_country] => US [patent_app_date] => 2001-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13358 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165181.pdf [firstpage_image] =>[orig_patent_app_number] => 09965551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545165 [patent_doc_number] => 20020137712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => '69109, a novel human tyrosine phosphatase and uses therefor' [patent_app_type] => new [patent_app_number] => 09/963204 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 36466 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137712.pdf [firstpage_image] =>[orig_patent_app_number] => 09963204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136043 [patent_doc_number] => 20040043948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Antisense modulation of interleukin 8 expression' [patent_app_type] => new [patent_app_number] => 09/960143 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25182 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043948.pdf [firstpage_image] =>[orig_patent_app_number] => 09960143 [rel_patent_id] =>[rel_patent_doc_number] =>)